{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:39:09Z","timestamp":1787315949303,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s40261-022-01122-0","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T04:02:32Z","timestamp":1646107352000},"page":"243-252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Costs and Health Benefits of Expanded Access to MDMA-assisted Therapy for Chronic and Severe PTSD in the USA: A Modeling Study"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4903-870X","authenticated-orcid":false,"given":"Anton L. V.","family":"Avance\u00f1a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8518-1143","authenticated-orcid":false,"given":"Elliot","family":"Marseille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,1]]},"reference":[{"key":"1122_CR1","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/jts.21848","volume":"26","author":"DG Kilpatrick","year":"2013","unstructured":"Kilpatrick DG, Resnick HS, Milanak ME, Miller MW, Keyes KM, Friedman MJ. National estimates of exposure to traumatic events and PTSD prevalence using DSM-IV and DSM-5 criteria. J Trauma Stress. 2013;26:537\u201347.","journal-title":"J Trauma Stress"},{"key":"1122_CR2","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00127-016-1208-5","volume":"51","author":"RB Goldstein","year":"2016","unstructured":"Goldstein RB, Smith SM, Chou SP, Saha TD, Jung J, Zhang H, et al. The epidemiology of DSM-5 posttraumatic stress disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Soc Psychiatry Psychiatr Epidemiol. 2016;51:1137\u201348.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"1122_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617\u201327.","journal-title":"Arch Gen Psychiatry"},{"key":"1122_CR4","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/da.23145","volume":"38","author":"B Nichter","year":"2021","unstructured":"Nichter B, Norman SB, Maguen S, Pietrzak RH. Moral injury and suicidal behavior among US combat veterans: Results from the 2019\u20132020 National Health and Resilience in Veterans Study. Depress Anxiety. 2021;38:606\u201314.","journal-title":"Depress Anxiety"},{"key":"1122_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1001\/jama.2015.8370","volume":"314","author":"MM Steenkamp","year":"2015","unstructured":"Steenkamp MM, Litz BT, Hoge CW, Marmar CR. Psychotherapy for military-related PTSD: a review of randomized clinical trials. JAMA. 2015;314:489\u2013500.","journal-title":"JAMA"},{"key":"1122_CR6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1001\/archinte.167.5.476","volume":"167","author":"KH Seal","year":"2007","unstructured":"Seal KH, Bertenthal D, Miner CR, Sen S, Marmar C. Bringing the war back home: mental health disorders among 103 788 US veterans returning from Iraq and Afghanistan seen at Department of Veterans Affairs facilities. Arch Intern Med. 2007;167:476.","journal-title":"Arch Intern Med"},{"key":"1122_CR7","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/jts.21956","volume":"27","author":"EK Dursa","year":"2014","unstructured":"Dursa EK, Reinhard MJ, Barth SK, Schneiderman AI. Prevalence of a Positive Screen for PTSD Among OEF\/OIF and OEF\/OIF-Era Veterans in a Large Population-Based Cohort. J Trauma Stress. 2014;27:542\u20139.","journal-title":"J Trauma Stress"},{"key":"1122_CR8","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1056\/NEJM198712243172604","volume":"317","author":"JE Helzer","year":"1987","unstructured":"Helzer JE, Robins LN, McEvoy L. Post-traumatic stress disorder in the general population: findings of the Epidemiologic Catchment Area Survey. N Engl J Med. 1987;317:1630\u20134.","journal-title":"N Engl J Med"},{"key":"1122_CR9","doi-asserted-by":"publisher","first-page":"1753940","DOI":"10.1080\/20008198.2020.1753940","volume":"11","author":"R von der Warth","year":"2020","unstructured":"von der Warth R, Dams J, Grochtdreis T, K\u00f6nig H-H. Economic evaluations and cost analyses in posttraumatic stress disorder: a systematic review. Eur J Psychotraumatology. 2020;11:1753940.","journal-title":"Eur J Psychotraumatology."},{"key":"1122_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/NMD.0000000000000432","volume":"204","author":"MG Haviland","year":"2016","unstructured":"Haviland MG, Banta JE, Sonne JL, Przekop P. Posttraumatic stress disorder\u2013related hospitalizations in the United States (2002\u20132011): rates, co-occurring illnesses, suicidal ideation\/self-harm, and hospital charges. J Nerv Ment Dis. 2016;204:78\u201386.","journal-title":"J Nerv Ment Dis"},{"key":"1122_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/MLR.0b013e31815dc5d2","volume":"46","author":"A Kartha","year":"2008","unstructured":"Kartha A, Brower V, Saitz R, Samet JH, Keane TM, Liebschutz J. The impact of trauma exposure and post-traumatic stress disorder on healthcare utilization among primary care patients. Med Care. 2008;46:388\u201393.","journal-title":"Med Care"},{"key":"1122_CR12","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.7205\/MILMED-D-15-00585","volume":"181","author":"KJ Vyas","year":"2016","unstructured":"Vyas KJ, Fesperman SF, Nebeker BJ, Gerard SK, Boyd ND, Delaney EM, et al. Preventing PTSD and depression and reducing healthcare costs in the military: a call for building resilience among service members. Mil Med. 2016;181:1240\u20137.","journal-title":"Mil Med"},{"key":"1122_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1037\/a0030549","volume":"10","author":"PW Tuerk","year":"2013","unstructured":"Tuerk PW, Wangelin B, Rauch SAM, Dismuke CE, Yoder M, Myrick H, et al. Health service utilization before and after evidence-based treatment for PTSD. Psychol Serv. 2013;10:401\u20139.","journal-title":"Psychol Serv"},{"key":"1122_CR14","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1111\/pme.12045","volume":"15","author":"SD Outcalt","year":"2014","unstructured":"Outcalt SD, Yu Z, Hoen HM, Pennington TM, Krebs EE. Health care utilization among veterans with pain and posttraumatic stress symptoms. Pain Med. 2014;15:1872\u20139.","journal-title":"Pain Med"},{"key":"1122_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1037\/h0099399","volume":"20","author":"E Kaier","year":"2014","unstructured":"Kaier E, Possemato K, Lantinga LJ, Maisto SA, Ouimette P. Associations between PTSD and healthcare utilization among OEF\/OIF veterans with hazardous alcohol use. Traumatology. 2014;20:142\u20139.","journal-title":"Traumatology"},{"key":"1122_CR16","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3109\/08039488.2015.1005023","volume":"69","author":"C Steinert","year":"2015","unstructured":"Steinert C, Hofmann M, Leichsenring F, Kruse J. The course of PTSD in naturalistic long-term studies: high variability of outcomes. A systematic review. Nord J Psychiatry. 2015;69:483\u201396.","journal-title":"Nord J Psychiatry"},{"key":"1122_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.cpr.2014.03.002","volume":"34","author":"N Morina","year":"2014","unstructured":"Morina N, Wicherts JM, Lobbrecht J, Priebe S. Remission from post-traumatic stress disorder in adults: a systematic review and meta-analysis of long term outcome studies. Clin Psychol Rev. 2014;34:249\u201355.","journal-title":"Clin Psychol Rev"},{"key":"1122_CR18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.pnpbp.2016.01.015","volume":"70","author":"RJ Koek","year":"2016","unstructured":"Koek RJ, Schwartz HN, Scully S, Langevin J-P, Spangler S, Korotinsky A, et al. Treatment-refractory posttraumatic stress disorder (TRPTSD): a review and framework for the future. Prog Neuropsychopharmacol Biol Psychiatry. 2016;70:170\u2013218.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1122_CR19","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s00213-019-05249-5","volume":"236","author":"MC Mithoefer","year":"2019","unstructured":"Mithoefer MC, Feduccia AA, Jerome L, Mithoefer A, Wagner M, Walsh Z, et al. MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for Phase 3 trials based on pooled analysis of six Phase 2 randomized controlled trials. Psychopharmacology. 2019;236:2735\u201345.","journal-title":"Psychopharmacology"},{"key":"1122_CR20","volume-title":"Treatment for posttraumatic stress disorder in military and veteran populations: final assessment","author":"Institute of Medicine","year":"2014","unstructured":"Institute of Medicine. Treatment for posttraumatic stress disorder in military and veteran populations: final assessment. Washington, D.C.: National Academies Press; 2014."},{"key":"1122_CR21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1176\/appi.ajp.162.2.214","volume":"162","author":"R Bradley","year":"2005","unstructured":"Bradley R, Greene J, Russ E, Dutra L. A multidimensional meta-analysis of psychotherapy for PTSD. Am J Psychiatry. 2005;162:214\u201327.","journal-title":"Am J Psychiatry"},{"key":"1122_CR22","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","volume":"27","author":"JM Mitchell","year":"2021","unstructured":"Mitchell JM, Bogenschutz M, Lilienstein A, Harrison C, Kleiman S, Parker-Guilbert K, et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled Phase 3 study. Nat Med. 2021;27:1025\u201333.","journal-title":"Nat Med"},{"key":"1122_CR23","unstructured":"Multidisciplinary Association for Psychedelic Studies. MDMA-assisted psychotherapy. 2021. https:\/\/maps.org\/research\/mdma. Accessed 9 Jul 2021."},{"key":"1122_CR24","doi-asserted-by":"crossref","unstructured":"Marseille E, Mitchell JM, Kahn JG. Updated cost-effectiveness of MDMA-assisted therapy for the treatment of PTSD: findings from a Phase 3 trial. PLoS One. 2022 (In press).","DOI":"10.1371\/journal.pone.0263252"},{"key":"1122_CR25","doi-asserted-by":"publisher","first-page":"e0239997","DOI":"10.1371\/journal.pone.0239997","volume":"15","author":"E Marseille","year":"2020","unstructured":"Marseille E, Kahn JG, Yazar-Klosinski B, Doblin R. The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD. PLoS ONE. 2020;15:e0239997.","journal-title":"PLoS ONE"},{"key":"1122_CR26","volume-title":"Cost-effectiveness in health and medicine","year":"2017","unstructured":"Neumann PJ, Sanders GD, Russell LB, Siegel JE, Ganiats TG, editors. Cost-effectiveness in health and medicine. 2nd ed. New York: Oxford University Press; 2017.","edition":"2"},{"key":"1122_CR27","doi-asserted-by":"publisher","first-page":"f1049","DOI":"10.1136\/bmj.f1049","volume":"346","author":"D Husereau","year":"2013","unstructured":"Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BMJ. 2013;346:f1049\u2013f1049.","journal-title":"BMJ"},{"key":"1122_CR28","unstructured":"Office of Disease Prevention and Health Promotion. Increase the proportion of adults with serious mental illness who get treatment. Healthy People 2030. 2021. https:\/\/health.gov\/healthypeople\/objectives-and-data\/browse-objectives\/mental-health-and-mental-disorders\/increase-proportion-adults-serious-mental-illness-who-get-treatment-mhmd-04. Accessed 9 Jul 2021."},{"key":"1122_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S2215-0366(16)30024-4","volume":"3","author":"D Chisholm","year":"2016","unstructured":"Chisholm D, Sweeny K, Sheehan P, Rasmussen B, Smit F, Cuijpers P, et al. Scaling-up treatment of depression and anxiety: a global return on investment analysis. Lancet Psychiatry. 2016;3:415\u201324.","journal-title":"Lancet Psychiatry"},{"key":"1122_CR30","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1017\/S2045796016000408","volume":"26","author":"D Chisholm","year":"2017","unstructured":"Chisholm D, Heslin M, Docrat S, Nanda S, Shidhaye R, Upadhaya N, et al. Scaling-up services for psychosis, depression and epilepsy in sub-Saharan Africa and South Asia: development and application of a mental health systems planning tool (OneHealth). Epidemiol Psychiatr Sci. 2017;26:234\u201344.","journal-title":"Epidemiol Psychiatr Sci."},{"key":"1122_CR31","unstructured":"National Institute of Mental Health. Post-traumatic stress disorder (PTSD). 2017. https:\/\/www.nimh.nih.gov\/health\/statistics\/post-traumatic-stress-disorder-ptsd. Accessed 9 Jul 2021."},{"key":"1122_CR32","unstructured":"U.S. Census Bureau. Age and sex composition in the United States: 2019. https:\/\/www.census.gov\/data\/tables\/2019\/demo\/age-and-sex\/2019-age-sex-composition.html. Accessed 9 Jul 2021."},{"key":"1122_CR33","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11126-019-09632-5","volume":"90","author":"K Hefner","year":"2019","unstructured":"Hefner K, Rosenheck R. Multimorbidity among veterans diagnosed with PTSD in the Veterans Health Administration nationally. Psychiatr Q. 2019;90:275\u201391.","journal-title":"Psychiatr Q"},{"key":"1122_CR34","unstructured":"MAPS Public Benefit Corporation. Protocol MAPP1. 2020. http:\/\/maps.org\/mapp1. Accessed 9 Jul 2021."},{"key":"1122_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/0269881112456611","volume":"27","author":"MC Mithoefer","year":"2013","unstructured":"Mithoefer MC, Wagner M, Mithoefer A, Jerome L, Martin S, Yazar-Klosinski B, et al. Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. J Psychopharmacol. 2013;27:28\u201339.","journal-title":"J Psychopharmacol"},{"key":"1122_CR36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/archpsyc.60.4.369","volume":"60","author":"EA Walker","year":"2003","unstructured":"Walker EA, Katon W, Russo J, Ciechanowski P, Newman E, Wagner AW. Health care costs associated with posttraumatic stress disorder symptoms in women. Arch Gen Psychiatry. 2003;60:369.","journal-title":"Arch Gen Psychiatry"},{"key":"1122_CR37","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1001\/jama.2018.6072","volume":"319","author":"PJ Neumann","year":"2018","unstructured":"Neumann PJ, Cohen JT. QALYs in 2018\u2014advantages and concerns. JAMA. 2018;319:2473.","journal-title":"JAMA"},{"key":"1122_CR38","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jval.2019.02.009","volume":"22","author":"AS Pickard","year":"2019","unstructured":"Pickard AS, Law EH, Jiang R, Pullenayegum E, Shaw JW, Xie F, et al. United States valuation of EQ-5D-5L health states using an international protocol. Value Health. 2019;22:931\u201341.","journal-title":"Value Health."},{"key":"1122_CR39","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1371\/journal.pmed.0030190","volume":"3","author":"MS Milane","year":"2006","unstructured":"Milane MS, Suchard MA, Wong M-L, Licinio J. Modeling of the temporal patterns of fluoxetine prescriptions and suicide rates in the United States. PLoS Med. 2006;3:e190.","journal-title":"PLoS Med"},{"key":"1122_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1086\/505147","volume":"194","author":"RP Walensky","year":"2006","unstructured":"Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, et al. The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006;194:11\u20139.","journal-title":"J Infect Dis"},{"key":"1122_CR41","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/infdis\/jix349","volume":"216","author":"ED Borre","year":"2017","unstructured":"Borre ED, Hyle EP, Paltiel AD, Neilan AM, Sax PE, Freedberg KA, et al. The clinical and economic impact of attaining National HIV\/AIDS Strategy Treatment targets in the United States. J Infect Dis. 2017;216:798\u2013807.","journal-title":"J Infect Dis"},{"key":"1122_CR42","unstructured":"American Lung Association. Smoking cessation\u2014the economic benefits. 2020. https:\/\/www.lung.org\/policy-advocacy\/tobacco\/cessation\/smoking-cessation-economic-benefits. Accessed 9 Jul 2021."},{"key":"1122_CR43","first-page":"359","volume":"10","author":"CL Baker","year":"2018","unstructured":"Baker CL, Ding Y, Ferrufino CP, Kowal S, Tan J, Subedi P. A cost\u2013benefit analysis of smoking cessation prescription coverage from a US payer perspective. Clin Outcomes Res CEOR. 2018;10:359\u201370.","journal-title":"Clin Outcomes Res CEOR."},{"key":"1122_CR44","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1017\/S2045796020001018","volume":"29","author":"MJD Jordans","year":"2020","unstructured":"Jordans MJD, Kohrt BA. Scaling up mental healthcare and psychosocial support in low-resource settings: a roadmap to impact. Epidemiol Psychiatr Sci. 2020;29:e189.","journal-title":"Epidemiol Psychiatr Sci."},{"key":"1122_CR45","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3389\/fpsyt.2019.00650","volume":"10","author":"AA Feduccia","year":"2019","unstructured":"Feduccia AA, Jerome L, Yazar-Klosinski B, Emerson A, Mithoefer MC, Doblin R. Breakthrough for trauma treatment: safety and efficacy of MDMA-assisted psychotherapy compared to paroxetine and sertraline. Front Psychiatry. 2019;10:650.","journal-title":"Front Psychiatry."},{"key":"1122_CR46","unstructured":"Congressional Research Service. State marijuana \u201clegalization\u201d and federal drug law: a brief overview for Congress. https:\/\/fas.org\/sgp\/crs\/misc\/LSB10482.pdf. Accessed 9 Jul 2021."},{"key":"1122_CR47","unstructured":"Haffajee R, Mauri A. Cannabis liberalization in the US: the policy landscape. Health Aff. 2021.\u00a0https:\/\/www.healthaffairs.org\/do\/10.1377\/hpb20210518.36548\/full\/. Accessed 25 Feb 2022."},{"key":"1122_CR48","doi-asserted-by":"publisher","first-page":"1322399","DOI":"10.1080\/16549716.2017.1322399","volume":"10","author":"E Kazlauskas","year":"2017","unstructured":"Kazlauskas E. Challenges for providing healthcare in traumatized populations: barriers for PTSD treatments and the need for new developments. Glob Health Action. 2017;10:1322399.","journal-title":"Glob Health Action"},{"key":"1122_CR49","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1521\/psyc.2009.72.3.238","volume":"72","author":"N Sayer","year":"2009","unstructured":"Sayer N, Friedemann-S\u00e1nchez G, Spoont M, Murdoch M, Parker L, Chiros C, et al. A qualitative study of determinants of PTSD treatment initiation. Psychiatry. 2009;72:238\u201355.","journal-title":"Psychiatry"},{"key":"1122_CR50","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1521\/psyc.2011.74.3.207","volume":"74","author":"S Lord","year":"2011","unstructured":"Lord S, Wagner A, Russo J, Love J, Zatzick D. Assessing barriers to care and readiness for cognitive behavioral therapy in early acute care PTSD interventions. Psychiatry. 2011;74:207\u201323.","journal-title":"Psychiatry"},{"key":"1122_CR51","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/1469-7610.00635","volume":"41","author":"W Yule","year":"2000","unstructured":"Yule W, Bolton D, Udwin O, Boyle S, O\u2019Ryan D, Nurrish J. The long-term psychological effects of a disaster experienced in adolescence: I: the incidence and course of PTSD. J Child Psychol Psychiatry. 2000;41:503\u201311.","journal-title":"J Child Psychol Psychiatry"},{"key":"1122_CR52","first-page":"838","volume":"43","author":"MF Caldwell","year":"1992","unstructured":"Caldwell MF. Incidence of PTSD among staff victims of patient violence. Hosp Community Psychiatry. 1992;43:838\u20139.","journal-title":"Hosp Community Psychiatry"},{"key":"1122_CR53","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10903-006-9323-0","volume":"8","author":"HT de Bocanegra","year":"2006","unstructured":"de Bocanegra HT, Moskalenko S, Kramer EJ. PTSD, depression, prescription drug use, and healthcare utilization of Chinese workers affected by the WTC attacks. J Immigr Minor Health. 2006;8:203\u201310.","journal-title":"J Immigr Minor Health"},{"key":"1122_CR54","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1176\/ajp.2006.163.4.659","volume":"163","author":"Z Solomon","year":"2006","unstructured":"Solomon Z, Mikulincer M. Trajectories of PTSD: a 20-year longitudinal study. Am J Psychiatry. 2006;163:659\u201366.","journal-title":"Am J Psychiatry"},{"key":"1122_CR55","unstructured":"FAIR Health Consumer. Welcome to FAIR Health. 2021. http:\/\/www.fairhealthconsumer.org. Accessed 9 Jul 2021."},{"key":"1122_CR56","unstructured":"Centers for Medicare & Medicaid Services. Overview of the Medicare physician fee schedule search. 2021. https:\/\/www.cms.gov\/medicare\/physician-fee-schedule\/search\/overview. Accessed 9 Jul 2021."},{"key":"1122_CR57","first-page":"10","volume":"17","author":"JI Ivanova","year":"2011","unstructured":"Ivanova JI, Birnbaum HG, Chen L, Duhig AM, Dayoub EJ, Kantor ES, et al. Cost of post-traumatic stress disorder vs major depressive disorder among patients covered by Medicaid or private insurance. Am J Manag Care. 2011;17:10.","journal-title":"Am J Manag Care"},{"key":"1122_CR58","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1176\/ps.2009.60.12.1612","volume":"60","author":"D Chan","year":"2009","unstructured":"Chan D, Cheadle AD, Reiber G, Un\u00fctzer J, Chaney EF. Health care utilization and its costs for depressed veterans with and without comorbid PTSD symptoms. Psychiatr Serv. 2009;60:1612\u20137.","journal-title":"Psychiatr Serv"},{"key":"1122_CR59","first-page":"91","volume":"24","author":"TA Lavelle","year":"2018","unstructured":"Lavelle TA, Kommareddi M, Jaycox LH, Belsher B, Freed MC, Engel CC. Cost-effectiveness of collaborative care for depression and PTSD in military personnel. Am J Manag Care. 2018;24:91\u20138.","journal-title":"Am J Manag Care"},{"key":"1122_CR60","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/da.20074","volume":"21","author":"MD Marciniak","year":"2005","unstructured":"Marciniak MD, Lage MJ, Dunayevich E, Russell JM, Bowman L, Landbloom RP, et al. The cost of treating anxiety: the medical and demographic correlates that impact total medical costs. Depress Anxiety. 2005;21:178\u201384.","journal-title":"Depress Anxiety"},{"key":"1122_CR61","first-page":"1","volume":"69","author":"E Arias","year":"2020","unstructured":"Arias E, Xu J. United States life tables, 2018. Natl Vital Stat Rep. 2020;69:1\u201344.","journal-title":"Natl Vital Stat Rep"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-022-01122-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-022-01122-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-022-01122-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T14:19:39Z","timestamp":1666361979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-022-01122-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1122"],"URL":"https:\/\/doi.org\/10.1007\/s40261-022-01122-0","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"26 January 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received to conduct this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All authors have no conflict of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Data needed to replicate this study are found in the main text, cited references, and in the electronic supplementary material.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"ALVA validated, curated, analyzed, and interpreted the data, wrote the first draft of the manuscript, edited the manuscript, and is the guarantor of the study. JGK conceptualized the study, edited the manuscript, and provided oversight. EM conceptualized the study, curated, analyzed, and interpreted the data, edited the manuscript, and provided oversight and supervision. All authors approve the submission and publication of the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}